You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nicotinamide adenine dinucleotide

Showing 1 - 25 of 265
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NAD Trial in Berlin (Niagen, Placebo)

Not yet recruiting
  • NAD
  • Niagen
  • Placebo
  • Berlin, Germany
    Surgical Clinic, Campus Virchow-Klinikum / Campus Charité Mitte,
Aug 22, 2023

Genetic Variants in Nicotinamide Adenine Dinucleotide Synthesis

Active, not recruiting
  • Vacterl Association
  • Congenital Malformation
    • Rochester, Minnesota
      Mayo Clinic
    Jan 10, 2023

    Covid19, Long COVID-19, Post-COVID-19 Syndrome Trial in Ann Arbor (Naltrexone, NAD+)

    Completed
    • Covid19
    • +2 more
    • Ann Arbor, Michigan
      AgelessRx
    Jan 23, 2023

    Method Optimization for the Quantification of the NAD

    Completed
    • NAD
    • Laboratory method validation
    • Lausanne, Switzerland
      Clinical Innovation Lab.
    Sep 27, 2022

    Sarcopenia, Nicotinamide Adenine Dinucleotide Concentration, Muscle Quality and NAD+ Content Trial in Buffalo (Nicotinamide

    Recruiting
    • Sarcopenia
    • +2 more
    • Nicotinamide Riboside
    • Placebo
    • Buffalo, New York
      VA Western New York Healthcare System, Buffalo, NY
    Oct 19, 2021

    Mild Cognitive Impairment, NAD Trial in San Antonio (Nicotinamide riboside, Sugar Pill)

    Completed
    • Mild Cognitive Impairment
    • NAD
    • Nicotinamide riboside
    • Sugar Pill
    • San Antonio, Texas
    • +1 more
    Aug 31, 2021

    Mitochondrial Myopathies Trial in Helsinki (Niacin)

    Completed
    • Mitochondrial Myopathies
    • Niacin
    • Helsinki, Finland
      University of Helsinki
    Jan 21, 2021

    Ketoses, Metabolic, Ketogenic Dieting, Alcohol Intoxication Trial in Philadelphia (dietary supplement, other, drug)

    Not yet recruiting
    • Ketoses, Metabolic
    • +4 more
    • Ketone Supplement
    • +3 more
    • Philadelphia, Pennsylvania
      University of Pennsylvania Center for Studies of Addiction
    Sep 29, 2023

    Friedreich Ataxia Trial in Philadelphia (MIB-626)

    Active, not recruiting
    • Friedreich Ataxia
    • Philadelphia, Pennsylvania
      The Children's Hospital of Philadelphia
    Oct 26, 2022

    Cognitive Impairment, Sleep Quality Trial in Buffalo (Nicotinamide riboside, Placebo)

    Not yet recruiting
    • Cognitive Impairment
    • Sleep Quality
    • Nicotinamide riboside
    • Placebo
    • Buffalo, New York
    • +1 more
    Aug 10, 2022

    Systemic Lupus Erythematosus (Sle) Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Nicotinamide Riboside)

    Not yet recruiting
    • Systemic Lupus Erythematosus (Sle)
    • Nicotinamide Riboside
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Sep 15, 2023

    Enhance Immune Function Trial (NMN)

    Not yet recruiting
    • Enhance Immune Function
    • (no location specified)
    Aug 2, 2023

    Alzheimer, Dementia Trial in Bergen (Placebo, Nicotinamide Riboside supplementation 1000mg daily in total, Nicotinamide Riboside

    Recruiting
    • Alzheimer Disease
    • Dementia
    • Placebo
    • +2 more
    • Bergen, Vestland, Norway
    • +1 more
    Nov 25, 2022

    Healthy Trial in Bergen (nicotinamide riboside, nicotinamide mononucleotide)

    Recruiting
    • Healthy
    • nicotinamide riboside
    • nicotinamide mononucleotide
    • Bergen, Vestland, Norway
      Haukeland University Hospital
    Jan 25, 2023

    Glaucoma, Open-Angle Trial in United Kingdom (Nicotinomide, Matching )

    Not yet recruiting
    • Glaucoma, Open-Angle
    • Belfast, Northern Ireland, United Kingdom
    • +6 more
    Nov 15, 2022

    Skeletal Muscle Trial in Orlando (Deuterated nicotinamide (D4-NAM) IV infusion, Skeletal muscle biopsy, Skin tissue biopsy)

    Recruiting
    • Skeletal Muscle
    • Deuterated nicotinamide (D4-NAM) IV infusion
    • +2 more
    • Orlando, Florida
      AdventHealth Translational Research Institute
    Aug 2, 2022

    Distinct Alterations in Gut Microbiota Composition Among Women

    Completed
    • Recurrent Miscarriage
      • Hangzhou, China
        Hangzhou First People's Hospital
      Aug 14, 2023

      Ataxia Telangiectasia, ATM Gene Mutation Trial in Nijmegen (Vitamin B3)

      Completed
      • Ataxia Telangiectasia
      • ATM Gene Mutation
      • Vitamin B3
      • Nijmegen, Netherlands
        Radboudumc
      Jul 21, 2022

      Migraine Prophylaxis Trial in Dhaka (Nicotinic Acid 500 MG Extended Release Oral Tablet, Nicotinic Acid 1000 MG Extended Release

      Recruiting
      • Migraine Prophylaxis
      • Nicotinic Acid 500 MG Extended Release Oral Tablet
      • +2 more
      • Dhaka, Bangladesh
        BSMMU
      May 5, 2023

      Heart Failure, Systolic Trial in Seattle (nicotinamide riboside, Placebo)

      Completed
      • Heart Failure, Systolic
      • nicotinamide riboside
      • Placebo
      • Seattle, Washington
        University of Washington
      Jun 9, 2021

      Ulcerative Colitis Trial in Pittsburgh (Nicotinamide Riboside Chloride, Placebo, Standard of Care)

      Not yet recruiting
      • Ulcerative Colitis
      • Nicotinamide Riboside Chloride
      • +2 more
      • Pittsburgh, Pennsylvania
        UPMC Children's Hospital of Pittsburgh
      Oct 7, 2022

      Alcoholism Trial in Decatur (Pioglitazone)

      Terminated
      • Alcoholism
      • Decatur, Georgia
        Atlanta VA Medical Center
      Jan 20, 2022

      AKI Trial in Rochester (Nicotinamide Riboside + Pterostilbene, Placebo)

      Recruiting
      • AKI
      • Nicotinamide Riboside + Pterostilbene
      • Placebo
      • Rochester, Minnesota
        Mayo Clinic
      Feb 9, 2022

      Healthy Trial in Poznan (Cardio-pulmonary exercise test)

      Completed
      • Healthy
      • Cardio-pulmonary exercise test
      • Poznań, Poland
        Poznan University of Physical Education
      Nov 10, 2021

      Mitochondrial Myopathies Trial (Niacin)

      Completed
      • Mitochondrial Myopathies
      • Niacin
      • (no location specified)
      May 31, 2019